Vaccines

COVID-19 COVID-19 Vaccines Vaccine Safety Vaccine Development mRNA Vaccines Public Health COVID-19 Vaccine MMR Vaccine Covid-19 Covid-19 Vaccines

Lipid Nanoparticle Cargo, Not the Shell, Drives Dendritic Cell Fate, Belgian Study Finds

A preclinical Cell Reports study maps single-cell signatures that could guide safer vaccines or tolerogenic approaches.

Vaccine Skeptic Retsef Levi to Lead CDC COVID-19 Working Group

FDA Suspends Valneva’s Ixchiq Chikungunya Vaccine in the U.S. After New Serious Adverse Reports

HHS Under Kennedy Pulls Back From mRNA, Winding Down 22 BARDA Projects

HHS Axes $500 Million in BARDA mRNA Vaccine Projects, Drawing Intensifying Warnings

Europe Logs Record Chikungunya Outbreaks as Global Surge Intensifies

Vaccines Reprogram Lymph Node Stromal Cells Within Hours, Study Finds

JAMA Study Finds Vaccine Panel Conflicts Minimal Before Kennedy’s Overhaul

US Cuts $500 Million in mRNA Vaccine Research Funding

HHS Cancels $500M in mRNA Vaccine Contracts, Winding Down Respiratory Virus Efforts

RFK Jr. Terminates $500 Million in BARDA mRNA Vaccine Projects as Experts Warn of Consequences

HHS Withdraws $500 Million for mRNA Vaccine Research as Experts Warn of Pandemic Risks

GSK Secures $370 Million After CureVac US Patent Settlement

AI-Powered Pipeline Identifies Conserved T-Cell Targets for Universal Coronavirus Vaccines

Kennedy Halts $500 Million in mRNA Vaccine Contracts, Shifts Investment to Alternative Platforms

Lancet-Published NIH Study Reveals Children’s Immunity Gaps After COVID Measures

HHS Pulls Funding From 22 mRNA Vaccine Programs

Most U.S. Adults Opt Out of Fall COVID-19 Booster, Poll Finds

Moderna Cuts 10% of Global Workforce in Major Cost Overhaul

Virtual Reality Triggers Innate Immunity and Launches Vaccine Priming Trials